AbCellera to Participate at Upcoming Investor Conferences in September
News > Health News
Audio By Carbonatix
3:05 PM on Tuesday, August 12
The Associated Press
VANCOUVER, British Columbia--(BUSINESS WIRE)--Aug 12, 2025--
AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:
- Wells Fargo Healthcare Conference, September 3-5, 2025
- Morgan Stanley Annual Global Healthcare Conference, September 8-10, 2025
Visit AbCellera's Investor Relations website for additional information.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women's health, immunology, and oncology. For more information, please visit www.abcellera.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250812333835/en/
CONTACT: Inquiries
Media: Tiffany Chiu;media@abcellera.com, +1(236)521-6774
Partnering: Murray McCutcheon, Ph.D.;partnering@abcellera.com, +1(604)559-9005
Investor Relations: Peter Ahn;ir@abcellera.com, +1(778)729-9116
KEYWORD: NORTH AMERICA CANADA
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL MANAGED CARE ONCOLOGY
SOURCE: AbCellera Biologics Inc.
Copyright Business Wire 2025.
PUB: 08/12/2025 04:05 PM/DISC: 08/12/2025 04:06 PM
http://www.businesswire.com/news/home/20250812333835/en
